Recommendations of the Mexican College of Rheumatology for the Management of Spondyloarthritis.
Autor: | Reyes-Cordero G; Hospital Ángeles Chihuahua, Facultad de Medicina y Ciencias Biomédicas, Universidad Autónoma de Chihuahua, Chihuahua, México., Enríquez-Sosa F; Hospital Regional «General Ignacio Zaragoza», ISSSTE, Ciudad de México, México., Gomez-Ruiz C; Hospital General de México «Dr. Eduardo Liceaga», Ciudad de México, México., Gonzalez-Diaz V; Antiguo Hospital Civil de Guadalajara «Fray Antonio Alcalde», Guadalajara, Jalisco, México., Castillo-Ortiz JD; Unidad de Investigación en Enfermedades Crónico-Degenerativas, Guadalajara, Jalisco, México., Duran-Barragán S; Clínica de Investigación en Reumatología y Obesidad S.C. Instituto de Investigación en Reumatología y del Sistema Musculoesquelético, Departamento de Clínicas Médicas, Universidad de Guadalajara, Guadalajara, Jalisco, México., Duran-Ortiz JS; Servicio de Reumatología, Hospital General de Zona N.(o) 1, Instituto Mexicano del Seguro Social, Tepic, Nayarit, México., Espinosa-Morales R; Servicio de Reumatología, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de México, México., Gamez-Nava JI; Unidad de Investigación Biomédica 02, UMAE, Hospital de Especialidades Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, México; Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México., Gonzalez-Lopez L; Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, México., Julian-Martínez B; Servicio de Reumatología, Hospital General de Zona N.(o) 1, Instituto Mexicano del Seguro Social Delegación Hidalgo, Pachuca, Hidalgo, México., Mendoza-Fuentes A; Centro Médico ISSEMyM, Toluca, Estado de México, México., Ramos-Remus C; Unidad de Investigación en Enfermedades Crónico-Degenerativas, Guadalajara, Jalisco, México., Pacheco-Tena C; Facultad de Medicina y Ciencias Biomédicas, Universidad Autónoma de Chihuahua, Chihuahua, México., Burgos-Vargas R; Hospital General de México «Dr. Eduardo Liceaga», Universidad Nacional Autónoma de México, Ciudad de México, México. Electronic address: r.burgos.vargas@gmail.com. |
---|---|
Jazyk: | English; Spanish; Castilian |
Zdroj: | Reumatologia clinica [Reumatol Clin (Engl Ed)] 2021 Jan; Vol. 17 (1), pp. 37-45. Date of Electronic Publication: 2019 Jul 06. |
DOI: | 10.1016/j.reuma.2019.03.010 |
Abstrakt: | Objectives: To update the recommendations for the management of patients with Spondyloarthritis (SpA) in the Mexican population, and identify which variables could influence patient management. Material and Methods: A group of 15 experts in SpA translated, analyzed and modified the recommendations of the Mexican College of Rheumatology (CMR) and the International Society for the Assessment of Spondyloarthritis (ASAS)/European League Against Rheumatism (EULAR) 2016 group through a systematic review of the literature by two external reviewers during the period from 2015 to 2018 using the grade of recommendation, Oxford levels of evidence, percentage of concordance (Delphi). Results: Compared to previous recommendations, there were no significant changes from the year 2015. However, we modified the five fundamental principles and reduced the number of recommendations to ten by incorporating the first item in the text and combining five recommendations into two and adding a further recommendation. We confirmed the tendency to use glucocorticoids for patients with inflammatory activity and scarce access to biologicals. We identified the sociodemographic and clinical characteristics of patients with SpA and their influence on the application of the recommendations. Conclusions: The ten recommendations of the CMR and the analysis of the characteristics of the Mexican patients with SpA focussed on step therapy, including pharmacological and non-pharmacological therapies, in a spectrum from easily accessible to high-tech substances available to a small percentage of the population. (Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |